TRP starter grant: Development of a novel platelet inhibitor that blocks the CXCL12-CXCR4 axis to prevent and treat atherothrombosis
| Institution | Klinikum der Universität München |
|---|---|
| Project leader | Philipp von Hundelshausen |
| Site | München |
| Project type | Translational Research Project |
| Funding | € 150.000,00 |
| Begin | 01.07.2023 |
| End | 31.12.2024 |
Förderkennzeichen
81X2600281
Projektnummer
1780